Delving into the Latest Updates on Becro Ltd. with Synapse

概览

关联

21

项与 Becro Ltd. 相关的临床试验

CTIS2023-507285-24-00

/ Not yet recruiting临床3期

Non-inferiority Clinical Trial for Comparing the Efficacy and Tolerability of a new fixed-Combination Generic Formulation of Brimonidine 0.2%/Timolol 0.5% eye drops, solution in single-dose containers vs Combigan® eye drops, solution in Patients with Open Angle Glaucoma or Ocular Hypertension - BECRO/PS/ETHRA

开始日期2024-06-13

申办/合作机构

Becro Ltd.

NCT06025214

/ Recruiting临床1期

A Randomized, Single-dose, Open Label, Two-treatment, Two-sequence, Two-period, Crossover Study Under Fasting Conditions to Examine the Bioequivalence Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 500/50 Inhalation Powder/GSK in Healthy Volunteers

Bioequivalence study between two inhaler products of fixed dose combination of fluticasone propionate and salmeterol xinafoate inhalation powder

开始日期2023-08-22

申办/合作机构

润生药业有限公司

[+1]

NCT05982990

/ Active, not recruiting临床1期

A Randomized, Single-dose, Open Label, Two-treatment, Two-sequence, Two-period, Crossover Study Under Fasting Conditions to Examine the Bioequivalence Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Bioequivalence study between two inhaler products of fixed dose combination of fluticasone propionate and salmeterol xinafoate inhalation powder

开始日期2023-08-01

申办/合作机构

润生药业有限公司

[+1]

100 项与 Becro Ltd. 相关的临床结果

登录后查看更多信息

0 项与 Becro Ltd. 相关的专利（医药）

登录后查看更多信息

100 项与 Becro Ltd. 相关的药物交易

登录后查看更多信息

100 项与 Becro Ltd. 相关的转化医学